Clinical Trials Directory

Trials / Completed

CompletedNCT02099968

Comprehensive Lifestyle Modification for Patients With Hypertension and Metabolic Syndrome: a Multicenter Randomized Controlled Trial

Intensivierte Ernährungs- Und Lebensstilmodifikation Bei Patienten Mit Bluthochdruck Und Kardiometabolischer Risikokonstellation. Eine Zweizentrische Randomisiert-kontrollierte Interventionsstudie über 6 Monate

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
145 (actual)
Sponsor
Universität Duisburg-Essen · Academic / Other
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Different forms of diet, e.g. Mediterranean diet, DASH diet, or fasting, have demonstrated efficacy in reducing elevated blood pressure. Moreover, Mediterranean diet, and fasting seem to be effective in improving insulin sensitivity in type 2 diabetes. Further, studies on meditation or mindfulness-based interventions have shown positive effects in patients with hypertension and/or type 2 diabetes. Comprehensive Lifestyle Modification, this is a combination of diet, exercise, and stress management, have improved coronary atherosclerosis. However, no studies have yet investigated the effects of Comprehensive Lifestyle Modification in patients with metabolic syndrome and/or in combination with fasting therapy. This study is supported by a grant from the Corona-Foundation, Germany.

Conditions

Interventions

TypeNameDescription
BEHAVIORALComprehensive Lifestyle Modification* Fasting (1st week), followed by: * Vegetarian and modified DASH diet (plant-based, low-salt) * Aerobic exercise * Stress reduction techniques: progressive muscle relaxation, meditation, yoga
BEHAVIORALStandard Lifestyle Modification / modified DASH* Modified DASH (vegetarian focused, plant-based, low-salt) * Aerobic exercise * Stress reduction techniques: progressive muscle relaxation

Timeline

Start date
2014-04-01
Primary completion
2015-03-01
Completion
2015-12-01
First posted
2014-03-31
Last updated
2019-07-10

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT02099968. Inclusion in this directory is not an endorsement.